Trial Profile
A National, Multicenter, Non-interventional, Prospective, Longitudinal Study for Treatment With Botulinum Toxin A Injections in naive and Pre-treated Patients Suffering From Cervical Dystonia (Dysport)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms CDNISLongterm
- Sponsors Ipsen
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders
- 31 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2015 Planned End Date changed from 1 Apr 2016 to 1 Feb 2016 as reported by ClinicalTrials.gov